JP2017137296A5 - - Google Patents

Download PDF

Info

Publication number
JP2017137296A5
JP2017137296A5 JP2016248774A JP2016248774A JP2017137296A5 JP 2017137296 A5 JP2017137296 A5 JP 2017137296A5 JP 2016248774 A JP2016248774 A JP 2016248774A JP 2016248774 A JP2016248774 A JP 2016248774A JP 2017137296 A5 JP2017137296 A5 JP 2017137296A5
Authority
JP
Japan
Prior art keywords
rooibos
cha
tea
group
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016248774A
Other languages
English (en)
Japanese (ja)
Other versions
JP6735224B2 (ja
JP2017137296A (ja
Filing date
Publication date
Application filed filed Critical
Priority to US16/068,408 priority Critical patent/US10925919B2/en
Priority to EP17743872.8A priority patent/EP3409285A4/en
Priority to PCT/JP2017/000023 priority patent/WO2017130638A1/ja
Priority to CN201780006658.5A priority patent/CN108463234A/zh
Publication of JP2017137296A publication Critical patent/JP2017137296A/ja
Publication of JP2017137296A5 publication Critical patent/JP2017137296A5/ja
Application granted granted Critical
Publication of JP6735224B2 publication Critical patent/JP6735224B2/ja
Priority to US17/150,093 priority patent/US20210128664A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016248774A 2016-01-28 2016-12-22 アストロサイトのグルコース代謝活性化剤 Active JP6735224B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US16/068,408 US10925919B2 (en) 2016-01-28 2017-01-04 Agent for activating astrocyte glucose metabolism
EP17743872.8A EP3409285A4 (en) 2016-01-28 2017-01-04 AGENT FOR THE ACTIVATION OF ASTROCYTIC GLUCOSE METABOLISM
PCT/JP2017/000023 WO2017130638A1 (ja) 2016-01-28 2017-01-04 アストロサイトのグルコース代謝活性化剤
CN201780006658.5A CN108463234A (zh) 2016-01-28 2017-01-04 星形胶质细胞的葡萄糖代谢激活剂
US17/150,093 US20210128664A1 (en) 2016-01-28 2021-01-15 Agent for Activating Astrocyte Glucose Metabolism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016013957 2016-01-28
JP2016013957 2016-01-28

Publications (3)

Publication Number Publication Date
JP2017137296A JP2017137296A (ja) 2017-08-10
JP2017137296A5 true JP2017137296A5 (cg-RX-API-DMAC7.html) 2019-11-14
JP6735224B2 JP6735224B2 (ja) 2020-08-05

Family

ID=59564595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016248774A Active JP6735224B2 (ja) 2016-01-28 2016-12-22 アストロサイトのグルコース代謝活性化剤

Country Status (4)

Country Link
US (2) US10925919B2 (cg-RX-API-DMAC7.html)
EP (1) EP3409285A4 (cg-RX-API-DMAC7.html)
JP (1) JP6735224B2 (cg-RX-API-DMAC7.html)
CN (1) CN108463234A (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7025145B2 (ja) * 2017-07-13 2022-02-24 株式会社メガチップス 電子メロディ特定装置、プログラム、及び電子メロディ特定方法
JP7088777B2 (ja) * 2018-08-09 2022-06-21 花王株式会社 Ｇｌｕｔ１発現亢進剤
AU2019336229A1 (en) * 2018-09-07 2021-03-18 Sotio, LLC Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof
CN114457045B (zh) * 2022-02-25 2023-07-14 中国人民解放军军事科学院军事医学研究院 抑制Slc2a1的RNAi腺相关病毒及其制备和应用
WO2025127072A1 (ja) * 2023-12-14 2025-06-19 協和ファーマケミカル株式会社 グルコーストランスポーター１の発現促進剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01283227A (ja) 1988-05-02 1989-11-14 Nonogawa Shoji:Kk 抗変異原剤
JPH05246866A (ja) 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk 脳代謝促進・脳機能改善剤
JP3241609B2 (ja) * 1996-09-20 2001-12-25 サントリー株式会社 甜茶抽出物を有効成分とする医薬並びにこれを配合した食品および化粧品
JP2002532416A (ja) 1998-12-17 2002-10-02 マインドセット・バイオファーマシューティカルズ・（ユーエスエイ）・インコーポレイテッド 脳のグルコース利用の増進
CN1370528A (zh) * 2001-02-21 2002-09-25 陈建操 治疗失眠、精神和心理障碍疾病的药物
WO2003001881A2 (en) * 2001-06-26 2003-01-09 New York State Office Of Mental Health Cell-based high-throughput screening methods
JP2004307443A (ja) 2003-04-10 2004-11-04 Shiseido Co Ltd カスパーゼ−９活性阻害剤含有組成物
KR20070078527A (ko) * 2006-01-27 2007-08-01 초임계연구소 주식회사 초임계 이산화탄소를 이용한 카페인이 제거된 차의제조방법
JP2007297304A (ja) 2006-04-28 2007-11-15 Kao Corp 大脳疲労回復剤
PL2053050T3 (pl) * 2007-10-23 2012-01-31 Kneipp Gmbh Podobny do aspalatyny dihydrochalkon i sposób jego wytwarzania
RU2496502C2 (ru) 2008-05-09 2013-10-27 Маунт Синай Скул Оф Медсин Способы профилактики и лечения нейродегенеративных заболеваний
FR2934160B1 (fr) 2008-07-25 2012-12-07 Lvmh Rech Procede de preparation d'un extrait lipophile de vigne.
EP2161026B1 (de) * 2008-09-05 2012-12-26 Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & Co. KG Kombination von Extrakten aus verschiedenen Pflanzen zur Verbesserung der Symptome von Demenzerkrankungen
KR100997078B1 (ko) * 2009-04-29 2010-11-29 (주)보성녹차테크 다엽 식용유 및 그 제조방법
JP5944325B2 (ja) 2009-12-18 2016-07-05 エクソドス ライフ サイエンシーズ リミテッド パートナーシップ 皮膚の炎症を治療するための方法及び組成物
CA2856599C (en) * 2011-11-29 2017-05-30 Amino Up Chemical Co., Ltd. Composition comprising vicenin-2 having a beneficial effect on neurological and/or cognitive function
JP6217038B2 (ja) 2012-02-03 2017-10-25 学校法人同志社 蛋白質糖化反応阻害剤
CN102613345A (zh) * 2012-04-17 2012-08-01 徐州绿之野生物食品有限公司 银杏红茶及其制备方法
CN102669345A (zh) * 2012-05-20 2012-09-19 北京绿源求证科技发展有限责任公司 一种养脑的营养食品养脑茶冲剂
JP2014118406A (ja) 2012-12-19 2014-06-30 Concord Co Ltd Ｏｐｈ活性増強剤
WO2014123305A2 (ko) * 2013-02-08 2014-08-14 주식회사 파미니티 민들레 추출물 또는 민들레 함유 복합 추출물을 유효성분으로 하는 남성 갱년기 예방, 개선 또는 치료용 조성물
CN103087828B (zh) * 2013-02-21 2016-04-27 云南天宏香精香料有限公司 一种滇红精油及其制备方法
CN103749919B (zh) * 2013-12-27 2015-04-22 北京康比特体育科技股份有限公司 一种提神醒脑的凝胶型糖果及其制备方法
CN104322736A (zh) * 2014-10-10 2015-02-04 张成海 一种袋装植物型醒脑提神茶饮
CN105037569B (zh) * 2015-05-19 2017-11-03 湘潭大学 一种甜叶悬钩子水溶性多糖用于保护肝脏及激活乙醛脱氢酶的应用
CN105237598B (zh) * 2015-09-24 2017-12-22 安徽农业大学 一种名为茶山奈苷b的黄酮氧苷类化合物及其制备方法和应用
JP2018177748A (ja) 2017-04-21 2018-11-15 花王株式会社 アストロサイトのグルコース代謝活性化剤

Similar Documents

Publication Publication Date Title
JP2017137296A5 (cg-RX-API-DMAC7.html)
WO2015101957A3 (en) Inhibitors of glutaminase
CA2956871C (en) Compounds active towards bromodomains
EP4635570A3 (en) Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders
WO2016073738A3 (en) Immunoregulatory agents
WO2016064082A3 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
WO2010030813A3 (en) Methods for inhibiting ocular angiogenesis
EP4520828A3 (en) Compositions and methods for the treatment of aberrant angiogenesis
EP4327880A3 (en) Solid state form of ribociclib succinate
WO2009068246A3 (en) Methods of treating obesity and metabolic disorders
WO2015104658A3 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
MX2017008196A (es) Composiciones basadas en semillas vegetales y usos de estas.
WO2014100351A3 (en) 8'-hydroxy-dihydroergotamine compounds and compositions
WO2018178243A3 (en) Dihydrotetrabenazine for use in the treatment a movement disorder
WO2011163319A3 (en) Activation of amp-protein activated kinase by oxaloacetate compounds
EP3694331A4 (en) INDAZOLYL-SPIRO [2,3] HEXANCARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
WO2015106215A3 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
HK1232145A1 (zh) 雙功能化合物和用於降低尿酸水平的用途
MX2019002432A (es) Bebidas saborizadas.
WO2012017435A8 (en) Soybean extracts for the treatment of hepatic disorders
NZ747445A (en) Composition containing caffeine and cycloalanylalanine
WO2016178510A3 (ko) 진세노사이드 Ｆ1 또는 Ｒｇ3를 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
MX2017008195A (es) Composiciones de especias y usos de estas.
WO2016093554A3 (ko) 신규한 4-(아릴)-n-(2-알콕시티에노[3,2-b]피라진-3-일)-피페라진-1-카복스아미드 유도체 및 이의 항증식 효과